DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Evaluating the role of Burkholderia pseudomallei K96243 toxins BPSS0390, BPSS0395, and BPSS1584 in persistent infection

Abstract

Burkholderia pseudomallei is the causative agent of melioidosis, a disease with a mortality rate of up to 40% even with treatment. Despite the ability of certain antibiotics to control initial infection, relapse occurs in treated patients. The inability of antibiotics to clear this bacterial infection is in part due to persistence, an evasion mechanism against antibiotics and the effect of host defenses. Evaluation of antibiotic efficacy against B. pseudomallei revealed that up to 48% of in vitro grown populations can survive in a persister state. Toxin–antitoxin (TA) systems have been previously implicated in modulating bacterial persistence. Here, we generated three isogenic TA mutants and found that loss of each toxin gene did not alter antibiotic persistence or macrophage survival. In response to macrophage–induced persistence, all three toxin mutants demonstrated increased intracellular susceptibility to levofloxacin which in part was due to the inability of the mutants to induce persistence after nitric oxide or nutrient starvation. In an inhalational model of murine melioidosis, both ΔBPSS0395 and ΔBPSS1584 strains were attenuated, and treatment with levofloxacin led to significant reduction in lung colonisation and reduced splenic colonisation by ΔBPSS0395. Based on our findings, these toxins deserve additional evaluation as putative therapeutic targets.

Authors:
 [1]; ORCiD logo [2]; ORCiD logo [2]; ORCiD logo [1]
  1. Univ. of Texas Medical Branch, Galveston, TX (United States)
  2. Los Alamos National Lab. (LANL), Los Alamos, NM (United States)
Publication Date:
Research Org.:
Los Alamos National Lab. (LANL), Los Alamos, NM (United States)
Sponsoring Org.:
Defense Threat Reduction Agency (DTRA); USDOE
OSTI Identifier:
1572326
Report Number(s):
LA-UR-19-21497
Journal ID: ISSN 1462-5814
Grant/Contract Number:  
89233218CNA000001
Resource Type:
Accepted Manuscript
Journal Name:
Cellular Microbiology
Additional Journal Information:
Journal Volume: 21; Journal Issue: 12; Journal ID: ISSN 1462-5814
Publisher:
Wiley
Country of Publication:
United States
Language:
English
Subject:
59 BASIC BIOLOGICAL SCIENCES; Biological Science; Burkholderia pseudomallei; melioidosis; persistence; toxin-antitoxin; chronic infection

Citation Formats

Ross, Brittany N., Micheva‐Viteva, Sofiya N., Hong‐Geller, Elizabeth, and Torres, Alfredo G. Evaluating the role of Burkholderia pseudomallei K96243 toxins BPSS0390, BPSS0395, and BPSS1584 in persistent infection. United States: N. p., 2019. Web. doi:10.1111/cmi.13096.
Ross, Brittany N., Micheva‐Viteva, Sofiya N., Hong‐Geller, Elizabeth, & Torres, Alfredo G. Evaluating the role of Burkholderia pseudomallei K96243 toxins BPSS0390, BPSS0395, and BPSS1584 in persistent infection. United States. https://doi.org/10.1111/cmi.13096
Ross, Brittany N., Micheva‐Viteva, Sofiya N., Hong‐Geller, Elizabeth, and Torres, Alfredo G. Sat . "Evaluating the role of Burkholderia pseudomallei K96243 toxins BPSS0390, BPSS0395, and BPSS1584 in persistent infection". United States. https://doi.org/10.1111/cmi.13096. https://www.osti.gov/servlets/purl/1572326.
@article{osti_1572326,
title = {Evaluating the role of Burkholderia pseudomallei K96243 toxins BPSS0390, BPSS0395, and BPSS1584 in persistent infection},
author = {Ross, Brittany N. and Micheva‐Viteva, Sofiya N. and Hong‐Geller, Elizabeth and Torres, Alfredo G.},
abstractNote = {Burkholderia pseudomallei is the causative agent of melioidosis, a disease with a mortality rate of up to 40% even with treatment. Despite the ability of certain antibiotics to control initial infection, relapse occurs in treated patients. The inability of antibiotics to clear this bacterial infection is in part due to persistence, an evasion mechanism against antibiotics and the effect of host defenses. Evaluation of antibiotic efficacy against B. pseudomallei revealed that up to 48% of in vitro grown populations can survive in a persister state. Toxin–antitoxin (TA) systems have been previously implicated in modulating bacterial persistence. Here, we generated three isogenic TA mutants and found that loss of each toxin gene did not alter antibiotic persistence or macrophage survival. In response to macrophage–induced persistence, all three toxin mutants demonstrated increased intracellular susceptibility to levofloxacin which in part was due to the inability of the mutants to induce persistence after nitric oxide or nutrient starvation. In an inhalational model of murine melioidosis, both ΔBPSS0395 and ΔBPSS1584 strains were attenuated, and treatment with levofloxacin led to significant reduction in lung colonisation and reduced splenic colonisation by ΔBPSS0395. Based on our findings, these toxins deserve additional evaluation as putative therapeutic targets.},
doi = {10.1111/cmi.13096},
journal = {Cellular Microbiology},
number = 12,
volume = 21,
place = {United States},
year = {2019},
month = {8}
}

Journal Article:
Free Publicly Available Full Text
Publisher's Version of Record

Citation Metrics:
Cited by: 10 works
Citation information provided by
Web of Science

Figures / Tables:

Table 1 Table 1: Strains and Primers

Save / Share:

Works referenced in this record:

Stochastic induction of persister cells by HipA through (p)ppGpp-mediated activation of mRNA endonucleases
journal, April 2015

  • Germain, Elsa; Roghanian, Mohammad; Gerdes, Kenn
  • Proceedings of the National Academy of Sciences, Vol. 112, Issue 16
  • DOI: 10.1073/pnas.1423536112

The IclR-Family Regulator BapR Controls Biofilm Formation in B. cenocepacia H111
journal, March 2014


Nitric Oxide from IFNγ-Primed Macrophages Modulates the Antimicrobial Activity of β-Lactams against the Intracellular Pathogens Burkholderia pseudomallei and Nontyphoidal Salmonella
journal, August 2014

  • Jones-Carson, Jessica; Zweifel, Adrienne E.; Tapscott, Timothy
  • PLoS Neglected Tropical Diseases, Vol. 8, Issue 8
  • DOI: 10.1371/journal.pntd.0003079

Recurrent Melioidosis in Patients in Northeast Thailand Is Frequently Due to Reinfection Rather than Relapse
journal, December 2005


Development of ceftazidime resistance in an acute Burkholderia pseudomallei infection
journal, August 2012


Persister cells, dormancy and infectious disease
journal, December 2006


Persisters, persistent infections and the Yin–Yang model
journal, January 2014


An allelic exchange system for compliant genetic manipulation of the select agents Burkholderia pseudomallei and Burkholderia mallei
journal, February 2009


Bacterial Persistence as a Phenotypic Switch
journal, September 2004

  • Balaban, Nathalie Q.; Merrin, Jack; Chait, Remy
  • Science, Vol. 305, Issue 5690, p. 1622-1625
  • DOI: 10.1126/science.1099390

Cell density and mobility protect swarming bacteria against antibiotics
journal, February 2010

  • Butler, Mitchell T.; Wang, Qingfeng; Harshey, Rasika M.
  • Proceedings of the National Academy of Sciences, Vol. 107, Issue 8
  • DOI: 10.1073/pnas.0910934107

Swarming motility: a multicellular behaviour conferring antimicrobial resistance
journal, January 2009


The role of metabolism in bacterial persistence
journal, January 2014

  • Amato, Stephanie M.; Fazen, Christopher H.; Henry, Theresa C.
  • Frontiers in Microbiology, Vol. 5
  • DOI: 10.3389/fmicb.2014.00070

Trimethoprim/sulfamethoxazole resistance in clinical isolates of Burkholderia pseudomallei
journal, April 2005

  • Wuthiekanun, Vanaporn; Cheng, Allen C.; Chierakul, Wirongrong
  • Journal of Antimicrobial Chemotherapy, Vol. 55, Issue 6
  • DOI: 10.1093/jac/dki151

Toxin-Antitoxin systems: their role in persistence, biofilm formation, and pathogenicity
journal, February 2014


Retraction Notice to: (p)ppGpp Controls Bacterial Persistence by Stochastic Induction of Toxin-Antitoxin Activity
journal, February 2018


Intracellular replication of the well-armed pathogen Burkholderia pseudomallei
journal, February 2016

  • Willcocks, Sam J.; Denman, Carmen C.; Atkins, Helen S.
  • Current Opinion in Microbiology, Vol. 29
  • DOI: 10.1016/j.mib.2015.11.007

Toxin-Antitoxin Modules Are Pliable Switches Activated by Multiple Protease Pathways
journal, July 2016

  • Muthuramalingam, Meenakumari; White, John; Bourne, Christina
  • Toxins, Vol. 8, Issue 7
  • DOI: 10.3390/toxins8070214

Mechanisms of antibiotic resistance in Burkholderia pseudomallei : implications for treatment of melioidosis
journal, December 2012


Experimental acute respiratory Burkholderia pseudomallei infection in BALB/c mice
journal, February 2009


Internalization of Salmonella by Macrophages Induces Formation of Nonreplicating Persisters
journal, January 2014


Bacterial Drug Tolerance under Clinical Conditions Is Governed by Anaerobic Adaptation but not Anaerobic Respiration
journal, July 2014

  • Hemsley, Claudia M.; Luo, Jamie X.; Andreae, Clio A.
  • Antimicrobial Agents and Chemotherapy, Vol. 58, Issue 10
  • DOI: 10.1128/AAC.02793-14

The IclR-family regulator BapR controls biofilm formation in B. cenocepacia H111
text, January 2014

  • Aguilar, Claudio; Schmid, Nadine; Lardi, Martina
  • Public Library of Science (PLoS)
  • DOI: 10.5167/uzh-105291

Burkholderia pseudomallei Infection in US Traveler Returning from Mexico, 2014
journal, October 2015

  • Cheng, Jennifer W.; Hayden, Mary K.; Singh, Kamaljit
  • Emerging Infectious Diseases, Vol. 21, Issue 10
  • DOI: 10.3201/eid2110.150815

The HicA toxin from Burkholderia pseudomallei has a role in persister cell formation
journal, March 2014

  • Butt, Aaron; Higman, Victoria A.; Williams, Christopher
  • Biochemical Journal, Vol. 459, Issue 2
  • DOI: 10.1042/BJ20140073

Migration of Dendritic Cells Facilitates Systemic Dissemination of Burkholderia pseudomallei
journal, July 2014

  • Williams, Natasha L.; Morris, Jodie L.; Rush, Catherine M.
  • Infection and Immunity, Vol. 82, Issue 10
  • DOI: 10.1128/IAI.01880-14

Melioidosis: refining management of a tropical time bomb
journal, March 2014


The molecular and cellular basis of pathogenesis in melioidosis: how does Burkholderia pseudomallei cause disease?
journal, November 2009


Identification of type II toxin-antitoxin modules in Burkholderia pseudomallei
journal, November 2012

  • Butt, Aaron; Müller, Claudia; Harmer, Nicholas
  • FEMS Microbiology Letters, Vol. 338, Issue 1
  • DOI: 10.1111/1574-6968.12032

Induction of Mouse Melioidosis with Meningitis by CD11b+ Phagocytic Cells Harboring Intracellular B. pseudomallei as a Trojan Horse
journal, August 2013


A Differential Effect of E. coli Toxin-Antitoxin Systems on Cell Death in Liquid Media and Biofilm Formation
journal, August 2009


Treatment and prophylaxis of melioidosis
journal, April 2014


The Effect of Environmental Conditions on Biofilm Formation of Burkholderia pseudomallei Clinical Isolates
journal, September 2012


Shelter in a Swarm
journal, November 2015


Strategies for Intracellular Survival of Burkholderia pseudomallei
journal, January 2011

  • Allwood, Elizabeth M.; Devenish, Rodney J.; Prescott, Mark
  • Frontiers in Microbiology, Vol. 2
  • DOI: 10.3389/fmicb.2011.00170

Burkholderia pseudomallei kynB plays a role in AQ production, biofilm formation, bacterial swarming and persistence
journal, April 2016


Characterization of the hipA7 allele of Escherichia coli and evidence that high persistence is governed by (p)ppGpp synthesis: Persistence and (p)ppGpp synthesis in E. coli
journal, November 2003


Burkholderia pseudomallei transcriptional adaptation in macrophages
journal, January 2012


Present and future therapeutic strategies for melioidosis and glanders
journal, March 2010

  • Estes, D. Mark; Dow, Steven W.; Schweizer, Herbert P.
  • Expert Review of Anti-infective Therapy, Vol. 8, Issue 3
  • DOI: 10.1586/eri.10.4

Prophages and Growth Dynamics Confound Experimental Results with Antibiotic-Tolerant Persister Cells
journal, December 2017


Molecular Mechanisms Underlying Bacterial Persisters
journal, April 2014


Role of persister cells in chronic infections: clinical relevance and perspectives on anti-persister therapies
journal, April 2011

  • Fauvart, M.; De Groote, V. N.; Michiels, J.
  • Journal of Medical Microbiology, Vol. 60, Issue 6
  • DOI: 10.1099/jmm.0.030932-0

Melioidosis
journal, February 2018

  • Wiersinga, W. Joost; Virk, Harjeet S.; Torres, Alfredo G.
  • Nature Reviews Disease Primers, Vol. 4, Issue 1
  • DOI: 10.1038/nrdp.2017.107

Adaptation and Antibiotic Tolerance of Anaerobic Burkholderia pseudomallei
journal, May 2011

  • Hamad, Mohamad A.; Austin, Chad R.; Stewart, Amanda L.
  • Antimicrobial Agents and Chemotherapy, Vol. 55, Issue 7
  • DOI: 10.1128/AAC.00953-10

Predicted global distribution of Burkholderia pseudomallei and burden of melioidosis
journal, January 2016

  • Limmathurotsakul, Direk; Golding, Nick; Dance, David A. B.
  • Nature Microbiology, Vol. 1, Issue 1
  • DOI: 10.1038/nmicrobiol.2015.8

Bacterial Persister Cell Formation and Dormancy
journal, September 2013

  • Wood, Thomas K.; Knabel, Stephen J.; Kwan, Brian W.
  • Applied and Environmental Microbiology, Vol. 79, Issue 23
  • DOI: 10.1128/AEM.02636-13

Pathogenesis of and immunity to melioidosis
journal, February 2000


Nitrogen Starvation Induces Persister Cell Formation in Escherichia coli
journal, February 2019


Figures/Tables have been extracted from DOE-funded journal article accepted manuscripts.